![Jan Egbert de Vries](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jan Egbert de Vries
Président chez
Artax, Inc.
Profil
Jan Egbert de Vries is the founder of Tr1x, Inc. He currently serves as the Chairman of Artax, Inc. He previously served as the Non-Executive Chairman of Cassiopea SpA from 2015 to 2021, Chairman of AIMM Therapeutics BV from 2018 to 2020, Director of Schering-Plough Research Institute from 1985 to 1988, Director-Human Immunology Department of DNAX Research, Inc. from 1989 to 1997, Senior VP-Drug Discovery & Early Development of Novartis AG from 1996 to 2009, and Head of Immunology Department of Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenh from 1969 to 1985.
He holds a doctorate from the University of Amsterdam and a graduate degree from the University of Utrecht.
Postes actifs de Jan Egbert de Vries
| Sociétés | Poste | Début |
|---|---|---|
Artax, Inc. | Président | - |
Anciens postes connus de Jan Egbert de Vries
| Sociétés | Poste | Fin |
|---|---|---|
Tr1x, Inc.
 Tr1x, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Directeur Général | 17/01/2024 |
AIMM Therapeutics BV
 AIMM Therapeutics BV Pharmaceuticals: MajorHealth Technology Develops therapeutic antibodies for the treatment of cancer and infectious diseases | Directeur Général | 31/12/2017 |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Corporate Officer/Principal | 01/01/2010 |
| NOVARTIS AG | Corporate Officer/Principal | 01/01/2009 |
DNAX Research, Inc.
 DNAX Research, Inc. Information Technology ServicesTechnology Services Develops cloud based enterprise and SaaS applications, websites, CRM & customer data platforms | Corporate Officer/Principal | 01/01/1997 |
Formation de Jan Egbert de Vries
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
93
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
University of Amsterdam
 University of Amsterdam Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Utrecht
 University of Utrecht Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Commercial Services |
Schering-Plough Research Institute
 Schering-Plough Research Institute Medical SpecialtiesHealth Technology Provides pharmaceutical research | Health Technology |
Cassiopea SpA
 Cassiopea SpA Pharmaceuticals: MajorHealth Technology Manufactures dermatological drugs | Health Technology |
DNAX Research, Inc.
DNAX Research, Inc. Information Technology ServicesTechnology Services Develops cloud based enterprise and SaaS applications, websites, CRM & customer data platforms | Technology Services |
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenh
 Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenh Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
AIMM Therapeutics BV
AIMM Therapeutics BV Pharmaceuticals: MajorHealth Technology Develops therapeutic antibodies for the treatment of cancer and infectious diseases | Health Technology |
Artax, Inc. | |
Tr1x, Inc.
Tr1x, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
